메뉴 건너뛰기




Volumn 39, Issue 1, 1977, Pages 45-50

Weekly high‐dose methotrexate‐citrovorum factor in osteogenic sarcoma. Pre‐surgical treatment of primary tumor and of overt pulmonary metastases

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FOLINIC ACID; METHOTREXATE; THYMIDINE; VINCRISTINE;

EID: 0017350847     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(197701)39:1<45::AID-CNCR2820390109>3.0.CO;2-T     Document Type: Article
Times cited : (63)

References (13)
  • 5
    • 84859952703 scopus 로고
    • Factors influencing the specificity of action of an antileukemic agent (aminopterin). Multiple treatment schedules plus delayed administration of citrovorum factor
    • (1955) Cancer Res , vol.15 , pp. 57-61
    • Goldin, A.1    Venditti, J.M.2    Humphreys, S.R.3
  • 7
    • 0015829609 scopus 로고
    • Favorable response of osteogenic sarcoma to high dose methotrexate with citrovorum rescue and radiation therapy
    • (1973) Cancer , vol.31 , pp. 1367-1373
    • Jaffe, N.1    Farber, S.2    Traggis, D.3
  • 9
    • 0016153679 scopus 로고
    • Progress report on high‐dose methotrexate (NSC‐740) with citrovorum rescue in the treatment of metastatic bone tumor
    • (1974) Cancer Chemother. Rep. , vol.58 , pp. 275-280
    • Jaffe, N.1
  • 12
    • 84989490642 scopus 로고
    • Methotrexate‐citrovorum (MTX‐CF): Effect of alkalinization (ALK) on nephrotoxicity and of weekly schedule on response. Submitted to Proceedings, ASCO/AACR, (abstr.).
    • (1976)
    • Pitman, S.1    Landwehr, D.2    Jaffe, N.3    Frei, E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.